D. E. Shaw & Co., Inc. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,414,232
-0.4%
1,947,739
+52.0%
0.01%0.0%
Q2 2023$8,444,940
-8.8%
1,281,478
-6.0%
0.01%
-10.0%
Q1 2023$9,255,429
+14.2%
1,363,097
+24.3%
0.01%
+11.1%
Q4 2022$8,102,654
-9.2%
1,096,435
+21.4%
0.01%
-18.2%
Q3 2022$8,926,000
-3.9%
903,429
+6.0%
0.01%0.0%
Q2 2022$9,286,000
+22.7%
851,978
+27.3%
0.01%
+57.1%
Q1 2022$7,569,000
-22.9%
669,147
+6.9%
0.01%
-12.5%
Q4 2021$9,823,000
-30.6%
626,060
-24.2%
0.01%
-38.5%
Q3 2021$14,156,000
-25.3%
825,900
-6.3%
0.01%
-18.8%
Q2 2021$18,958,000
+67.3%
881,347
+16.8%
0.02%
+45.5%
Q1 2021$11,332,000
+109.1%
754,429
+82.9%
0.01%
+120.0%
Q4 2020$5,419,000
+3.4%
412,459
-24.0%
0.01%0.0%
Q3 2020$5,241,000
-36.9%
542,541
-25.3%
0.01%
-50.0%
Q2 2020$8,304,000
+31.2%
725,904
+18.8%
0.01%0.0%
Q1 2020$6,330,000
+257.6%
611,012
+466.3%
0.01%
+400.0%
Q4 2019$1,770,000
-53.9%
107,893
-62.7%
0.00%
-60.0%
Q3 2019$3,838,000
+1223.4%
288,963
+1306.1%
0.01%
Q2 2019$290,000
-48.9%
20,550
-33.4%
0.00%
-100.0%
Q1 2019$568,000
-79.2%
30,845
-74.1%
0.00%
-66.7%
Q3 2018$2,728,000
-58.0%
118,872
-65.1%
0.00%
-62.5%
Q2 2018$6,494,000
+136.1%
340,896
+108.8%
0.01%
+100.0%
Q1 2018$2,751,000
+8.8%
163,275
-1.9%
0.00%
+33.3%
Q4 2017$2,529,000
-31.5%
166,392
-19.3%
0.00%
-50.0%
Q3 2017$3,693,000
+7.5%
206,293
-2.1%
0.01%0.0%
Q2 2017$3,434,000
-20.4%
210,649
-31.6%
0.01%
-25.0%
Q1 2017$4,313,000
-19.0%
308,112
-7.6%
0.01%
-11.1%
Q4 2016$5,322,000
-7.6%
333,619
-3.6%
0.01%
-10.0%
Q3 2016$5,758,000
+134.2%
346,055
+57.5%
0.01%
+100.0%
Q2 2016$2,459,000
+561.0%
219,757
+393.7%
0.01%
+400.0%
Q1 2016$372,000
+144.7%
44,512
+173.1%
0.00%
Q4 2015$152,000
-77.8%
16,297
-73.2%
0.00%
-100.0%
Q3 2015$685,000
-76.7%
60,700
-73.8%
0.00%
-75.0%
Q2 2015$2,945,000
-10.2%
232,062
-34.2%
0.00%
-20.0%
Q1 2015$3,281,000
-38.0%
352,781
-4.5%
0.01%
-28.6%
Q4 2014$5,288,000
+1126.9%
369,271
+790.1%
0.01%
+600.0%
Q3 2014$431,000
-83.4%
41,488
-74.1%
0.00%
-75.0%
Q2 2014$2,589,000
-27.9%
160,032
-27.5%
0.00%
-20.0%
Q1 2014$3,589,000
+457.3%
220,882
+325.9%
0.01%
+400.0%
Q4 2013$644,00051,8640.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders